PMID: 38724Jan 1, 1979

Muscular dystrophy in the mouse: neuromuscular transmission and the concept of functional denervation

Annals of the New York Academy of Sciences
J B Harris, R R Ribchester


The results of recent investigations by ourselves and others indicate that no form of denervation exists to any remarkable degree in dystrophic mouse skeletal muscles. This conclusion is based on the following information: Dystrophic nerve terminals liberate normal amounts of transmitter both spontaneously and during impulse-mediated activity. The characteristics of the release process, the size of the available store of transmitter, and the probability of release of transmitter in response to the invasion of an action potential appear to be normal. The sensitivity of the postsynaptic membrane to the transmitter is normal. Action potential generation in response to both direct and indirect excitation is normal. There is no unequivocal pharmacologic evidence of denervation in dystrophic skeletal muscle, even though dystrophic muscle fibers respond to surgical denervation in a normal fashion. Nerve terminal sprouting is extensive, but there is no evidence of collateral reinnervation.


Dec 1, 1986·Journal of the Neurological Sciences·J B Harris, S L Pollard
Jan 1, 1988·Progress in Neurobiology·A J McComasS Garner
May 1, 1980·Neuroscience Letters·A F Dulhunty, P C Vaughan
Dec 31, 1982·Neuroscience Letters·P S Rutherford, R J Boegman
May 31, 1989·Biochimica Et Biophysica Acta·A Martonosi
Oct 1, 1981·Acta Physiologica Scandinavica·R LibeliusS THESLEFF
Feb 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·G BulfieldK J Moore
Jan 1, 1988·The American Journal of Anatomy·D L BourkeF Taylor
Jul 1, 1982·Muscle & Nerve·A F Dulhunty, A A Valois
Sep 1, 1988·Arquivos de neuro-psiquiatria·L F Torres
Jan 1, 1986·The Anatomical Record·D L Bourke, M Ontell
Mar 9, 2006·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Dominique S Tews
Jun 7, 2005·Muscle & Nerve·Dominique S Tews


Mar 25, 1976·Nature·A PestronkJ W Griffin
Jan 1, 1977·Experimental Neurology·P A LavoieA Tenenhouse
Nov 1, 1975·Journal of the Neurological Sciences·M A Johnson, A Montgomery
Jun 1, 1975·The Journal of Physiology·P HuizarY Miyata
May 1, 1976·Experimental Neurology·P K LawA J McComas
Jul 1, 1977·Journal of Neurophysiology·S Carbonetto
Jan 1, 1978·The Journal of Physiology·S S Kelly
Jan 1, 1977·Journal of the Neurological Sciences·T J BiscoeC A Stirling
Jul 1, 1977·Experimental Neurology·P R HoweL Austin
Feb 1, 1975·Journal of the Neurological Sciences·P K Law, M R Caccia
Apr 1, 1975·Experimental Neurology·M Curran, D J Parry
Apr 1, 1975·Journal of Neurology, Neurosurgery, and Psychiatry·T J BiscoeU M Pehrson
Sep 1, 1975·The Journal of Physiology·J K Jansen, D C Van Essen
Apr 1, 1976·Experimental Neurology·P R HoweL Austin
Dec 1, 1972·European Journal of Pharmacology·W W Hofmann, S THESLEFF
Feb 1, 1973·Journal of the Neurological Sciences·W G Bradley, M Jenkison
Jun 1, 1974·The Journal of Physiology·M J Dennis, R Miledi
Aug 1, 1974·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·A J McComasA R Upton
May 1, 1971·Acta Physiologica Scandinavica·P Redfern, S THESLEFF
Jul 1, 1973·Journal of Neuropathology and Experimental Neurology·J J GilbertB Q Banker
Oct 1, 1973·Journal of Neurology, Neurosurgery, and Psychiatry·E R IsaacsG Henderson
Feb 15, 1974·Experientia·P K Law, H L Atwood
Aug 1, 1974·Experimental Neurology·M W MarshallP Wilson
Mar 1, 1972·Journal of the Neurological Sciences·J B HarrisJ Wing
Feb 1, 1972·Experimental Neurology·P K Law, H L Atwood
Feb 1, 1972·Journal of Neurology, Neurosurgery, and Psychiatry·T A Papapetropoulos, W G Bradley
Nov 1, 1971·Acta Physiologica Scandinavica·J B Harris, S THESLEFF
Dec 1, 1967·Journal of Neurology, Neurosurgery, and Psychiatry·A J McComas, K Mrozek
Jul 11, 1957·The Journal of Physiology·B KATZ, S THESLEFF
Jun 23, 1959·The Journal of Physiology·J AXELSSON, S THESLEFF
Dec 15, 1962·Experientia·J A BARSTAD
Sep 1, 1964·Archives of Neurology·J T CONRAD, G H GLASER
Jun 1, 1959·Journal of Cellular and Comparative Physiology·C L LII KLATZO
May 12, 1977·Nature·A Montgomery, L Swenarchuk

Related Concepts

Episodic Ataxia Type 1
Resting Potentials
Action Potentials
Epidermolysis Bullosa Dystrophica
Nerve Endings
Collateral Branch of Vessel
Muscle Fibers
Muscular Dystrophy

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.